KemOne ranked among the top searched stocks on three days within the past month.


As of 2:30 PM on the 5th, KemOne is trading at 4,295 KRW, up 0.59% from the previous day. This marks a 40.82% increase compared to October 23. KemOne is known as Korea's first non-clinical CRO company.

Over the past five days, individual investors have sold a net 535,596 shares, while foreign investors have bought a net 568,354 shares.


On November 4, KemOne was a market topic with the headline, "KemOne weak despite AstraZeneca's vaccine production news for March next year."



※ Source: AI Investment Assistant AI Lassiro


※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing